FDA’s Latest Post-Market Plan: Data-Mining Device Safety … And Then There’s MAUDE
This article was originally published in The Silver Sheet
Executive Summary
Data-mining software tools will be used by FDA to find troubling patterns with particular devices as part of the agency’s latest plan to beef up its post-market surveillance activities. However, “we haven’t determined the device areas in which we will implement data-mining,” CDRH Chief Scientist William Maisel said. Meanwhile, a new system will be piloted to replace the MAUDE adverse event database, and CDRH Director Jeffrey Shuren explains why Unique Device Identification and product registries will play an important role in the new post-market plan.
You may also be interested in...
Report: Registries Can Help With Post-Market Surveillance
Researchers argue that the U.S. needs a stronger system of registries to answer safety and effectiveness questions that can’t be addressed by size-limited pre-market studies.
News In Brief
Nonprofit groups close to inking agreement to collaborate on supplier accreditation program; CDRH’s compliance office to reorganize, creating new divisions and refocusing others; and more.